Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Medtronic (NYSE: MDT ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's routinely coming out ...

Medtronic, a global leader in healthcare technology, unveiled results from the Prospective Registry for Assessment of Acute ...

Medtronic will host a video webcast at 7:00 a.m. CST on November 19, 2024, to discuss results for its second quarter of full fiscal year 2025. The webcast can be accessed at ...

Medtronic remains an attractive investment ... surgical tools and robots, and patient monitoring systems, among others. MDT’s revenues are well-diversified by segment, with roughly an even ...

Netherlands: Royal Philips, a global leader in health technology, and Medtronic Neurovascular, a leading innovator in ...

Shares of Medtronic PLC MDT shed 1.38% to $87.04 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.96% to 5,695.94 and Dow ...

Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.

In the most recent trading session, Medtronic (MDT) closed at $90.60, indicating a +0.01% shift from the previous trading day.